Pacific Biosciences
PACB
#7514
Rank
NZ$0.70 B
Marketcap
NZ$2.35
Share price
-0.74%
Change (1 day)
6.96%
Change (1 year)

Market capitalization of Pacific Biosciences (PACB)

Market cap: NZ$0.70 Billion

As of April 2026 Pacific Biosciences has a market cap of NZ$0.70 Billion. This makes Pacific Biosciences the world's 7514th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Pacific Biosciences from 2010 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.70 B-23.17%
2025NZ$0.92 B-4.94%
2024NZ$0.97 B-76.6%
2023NZ$4.14 B42.41%
2022NZ$2.91 B-55.91%
2021NZ$6.60 B-1.83%
2020NZ$6.73 B475.97%
2019NZ$1.16 B-29.5%
2018NZ$1.65 B283.57%
2017NZ$0.43 B-14.98%
2016NZ$0.50 B-66.88%
2015NZ$1.53 B107.43%
2014NZ$0.73 B75.37%
2013NZ$0.42 B263.38%
2012NZ$0.11 B-40.97%
2011NZ$0.19 B-81.96%
2010NZ$1.09 B

End of Day market cap according to different sources

On Apr 2nd, 2026 the market cap of Pacific Biosciences was reported to be:

NZ$0.70 Billion
by Nasdaq info icon info icon
NZ$0.70 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Thermo Fisher Scientific
TMO
NZ$319.82 B 45,014.82%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$519.53 B 73,185.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$34.11 B 4,712.82%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
NZ$25.32 B 3,472.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Luminex
LMNX
NZ$3.06 B 332.48%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
NZ$8.87 M-98.75%๐Ÿ‡บ๐Ÿ‡ธ USA